Literature DB >> 6965858

A screening strategy for population studies in systemic lupus erythematosus. Series design.

M H Liang, R F Meenan, E S Cathcart, P H Schur.   

Abstract

A survey design which uses two tests in series greatly increases the efficiency of screening. We conducted a study to ascertain the sensitivity, specificity, and predictive value of a screening questionnaire for systemic lupus erythematosus (SLE) patients. A series design in which this questionnaire is used, followed by an antinuclear antibody test, increased the predictive value of a positive screening result by 5 to 10-fold, depending on estimates of disease prevalence. An empirical study of the series design identified two new cases of SLE and indicated that the use of a questionnaire based on accepted criteria is theoretically sound and practical. This approach should prove useful for population surveys of SLE to avoid the sampling and detection biases of previous epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965858     DOI: 10.1002/art.1780230204

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  [Systemic lupus erythematosus. A problem based approach].

Authors:  S Kleinert; M Feuchtenberger; H-P Tony
Journal:  Internist (Berl)       Date:  2010-08       Impact factor: 0.743

2.  Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk.

Authors:  Elizabeth W Karlson; Lori B Chibnik; Peter Kraft; Jing Cui; Brendan T Keenan; Bo Ding; Souyma Raychaudhuri; Lars Klareskog; Lars Alfredsson; Robert M Plenge
Journal:  Ann Rheum Dis       Date:  2010-03-16       Impact factor: 19.103

3.  Association of Trauma and Posttraumatic Stress Disorder With Incident Systemic Lupus Erythematosus in a Longitudinal Cohort of Women.

Authors:  Andrea L Roberts; Susan Malspeis; Laura D Kubzansky; Candace H Feldman; Shun-Chiao Chang; Karestan C Koenen; Karen H Costenbader
Journal:  Arthritis Rheumatol       Date:  2017-10-12       Impact factor: 10.995

4.  The performance of a point of care test for detection of anti-mutated citrullinated vimentin and rheumatoid factor in early rheumatoid arthritis.

Authors:  Preeda Rojanasantikul; Prapa Pattrapornpisut; Kulvara Anuruckparadorn; Wanruchada Katchamart
Journal:  Clin Rheumatol       Date:  2014-02-28       Impact factor: 2.980

5.  Validation of the Spanish version of a screening questionnaire for the detection of systemic lupus erythematosus.

Authors:  Francisco Javier Aceves-Avila; Martha Alicia Delgadillo-Ruano; César Ramos-Remus; Amparo Gómez-Vargas; Sergio Gutiérrez-Ureña
Journal:  Clin Rheumatol       Date:  2003-11-11       Impact factor: 2.980

6.  Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study.

Authors:  E J Giltay; H J Bernelot Moens; A H Riley; R G Tan
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

7.  Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis.

Authors:  Lori B Chibnik; Lisa A Mandl; Karen H Costenbader; Peter H Schur; Elizabeth W Karlson
Journal:  J Rheumatol       Date:  2009-02-17       Impact factor: 4.666

8.  Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies.

Authors:  Elizabeth W Karlson; Lori B Chibnik; Shelley S Tworoger; I-Min Lee; Julie E Buring; Nancy A Shadick; Joann E Manson; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-03

9.  [RheumaCheck: development and evaluation of a German language screening instrument for rheumatic diseases].

Authors:  Jutta G Richter; Ewa Wessel; Ralf Klimt; Reinhardt Willers; Matthias Schneider
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

10.  Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onset.

Authors:  Lori B Chibnik; Brendan T Keenan; Jing Cui; Katherine P Liao; Karen H Costenbader; Robert M Plenge; Elizabeth W Karlson
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.